3.43 (3.93%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Rhythm Pharmaceuticals, Inc.
Telephone
1.857.264.4280
Address
12th floor, 222 Berkeley Street, Boston, MA 02116-3748
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 58.71 - 122.2
Trade Value (12mth)
US$17,353,545.00
1 week
-3.66%
1 month
2.7%
YTD
-16.95%
1 year
39.74%
All time high
122.20
EPS 3 yr Growth
-10.60%
EBITDA Margin
-100.50%
Operating Cashflow
-$116m
Free Cash Flow Return
-35.50%
ROIC
-60.40%
Interest Coverage
-9.30
Quick Ratio
4.20
Shares Outstanding (Fully Diluted)
68m
HALO Sector
Healthcare
Next Company Report Date
03-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 06 May 26 | |
| 06 May 26 | |
| 05 May 26 | |
| 04 April 26 | |
| 27 March 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -3.2 | -4.34 | -3.11 | | | | ||
EPS (Fully Diluted) | $ | | | | | -3.2 | -4.34 | -3.11 | | | | ||
Growth | % | | | | | 7.9 | -35.5 | 28.4 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
